Table 4. Multivariable analysis of factors associated with current sexually transmitted infections in pregnant women, East New Britain, Papua New Guinea, 2015–2017*.
| Characteristic | Sexually transmitted infection, aOR (95% CI); p value |
||||
|---|---|---|---|---|---|
| Mycoplasma genitalium | Chlamydia trachomatis | Neisseria gonorrhoeae | Trichomonas vaginalis | >1 infection | |
| Clinic | |||||
| Vunapope | Referent | Referent | Referent | Referent | Referent |
| Nonga | 0.68 (0.28–1.62); 0.38 | 0.88 (0.43–1.78); 0.72 | 2.35 (0.76–7.32); 0.14 | 0.91 (0.42–1.97); 0.82 | 0.84 (0.43–1.63); 0.61 |
| Kerevat | 0.9 (0.43–1.88); 0.77 | 0.55 (0.28–1.09); 0.09 | 1.03 (0.3–3.5); 0.97 | 0.84 (0.41–1.72); 0.62 | 0.58 (0.31–1.11); 0.10 |
| Napapar | 0.76 (0.37–1.57); 0.46 | 0.9 (0.5–1.62); 0.73 | 0.99 (0.31–3.15); 0.98 | 1.09 (0.6–1.99); 0.77 | 0.64 (0.36–1.13); 0.12 |
| Paparatava |
0.86 (0.43–1.73); 0.68 |
0.86 (0.47–1.57); 0.62 |
2.04 (0.7–5.95); 0.19 |
1.08 (0.59–1.99); 0.79 |
1.01 (0.58–1.75); 0.97 |
| Age, y | |||||
| >35 | Referent | Referent | Referent | Referent | Referent |
| 25–34 | 0.76 (0.34–1.69); 0.50 | 2.47 (0.94–6.52); 0.07 | 1.01 (0.2–4.98); 0.99 | 1.85 (0.78–4.37); 0.16 | 1.7 (0.85–3.38); 0.13 |
| 16–24 |
1.21 (0.52–2.82); 0.66 |
3.39 (1.24–9.28); 0.02 |
1.86 (0.36–9.63); 0.46 |
2.31 (0.93–5.7); 0.07 |
2.45 (1.17–5.16); 0.02 |
| Gravidity | |||||
| Multigravida | Referent | Referent | Referent | Referent | Referent |
| Primigravida |
0.87 (0.46–1.65); 0.67 |
2.17 (1.29–3.64); <0.01 |
4.33 (1.74–10.75); <0.01 |
1.09 (0.62–1.92); 0.75 |
1.45 (0.87–2.42); 0.15 |
| Marital status | |||||
| Married/cohabiting | Referent | Referent | Referent | Referent | Referent |
| Single/separated |
1.06 (0.34–3.3); 0.92 |
1.31 (0.54–3.13); 0.55 |
0.44 (0.09–2.23); 0.32 |
4.48 (1.9–10.55); <0.01 |
1.6 (0.61–4.21); 0.34 |
| Vaginal discharge | |||||
| No symptoms | Referent | Referent | Referent | Referent | Referent |
| Abnormal discharge (current or before first antenatal clinic) |
1.17 (0.63–2.15); 0.62 |
1.29 (0.78–2.14); 0.33 |
1.45 (0.6–3.53); 0.41 |
1.56 (0.94–2.59); 0.09 |
1.29 (0.79–2.11); 0.31 |
| Has used modern contraception | |||||
| Yes | Referent | Referent | Referent | Referent | Referent |
| No |
1.82 (0.82–4.08); 0.14 |
1.04 (0.56–1.95); 0.90 |
0.77 (0.23–2.59); 0.67 |
1.27 (0.66–2.43); 0.47 |
1.17 (0.67–2.05); 0.57 |
| Employment status | |||||
| Unemployed | Referent | Referent | Referent | Referent | Referent |
| Employed |
0.89 (0.49–1.62); 0.71 |
1.27 (0.79–2.05); 0.32 |
2.66 (1.24–5.71); 0.01 |
0.96 (0.57–1.62); 0.89 |
1.29 (0.81–2.06); 0.28 |
| Urine nitrite | |||||
| Trace | 0.49 (0.11–2.12); 0.34 | 0.78 (0.25–2.43); 0.667 | 0.68 (0.08–5.55); 0.72 | 0.34 (0.07–1.61); 0.17 | 0.35 (0.11–1.11); 0.08 |
| Positive |
1.32 (0.58–3); 0.50 |
1.88 (0.94–3.74); 0.07 |
1.6 (0.5–5.09); 0.43 |
1.29 (0.6–2.76); 0.51 |
1.26 (0.62–2.58); 0.53 |
| Fever during pregnancy | |||||
| No | Referent | Referent | Referent | Referent | Referent |
| Yes (before first antenatal clinic) | 1.15 (0.66–1.99); 0.63 | 0.75 (0.46–1.24); 0.26 | 0.69 (0.29–1.65); 0.41 | 1.58 (0.99–2.53); 0.05 | 1 (0.63–1.57); 0.99 |
*aOR, adjusted odds ratio.